Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
US Army
Federal Trade Commission
Express Scripts
Harvard Business School

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,616,196

« Back to Dashboard

Which drugs does patent 8,616,196 protect, and when does it expire?

Patent 8,616,196 protects SYMBICORT and is included in one NDA.

Protection for SYMBICORT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has twenty-three patent family members in twenty-one countries.

Summary for Patent: 8,616,196

Title:Inhalation device and a method for assembling said inhalation device
Abstract: An inhalation device for delivering doses of medicament to a user comprising: --a canister (5), said canister being adapted to accommodate the medicament to be dispensed to a user, and --a counter (15) which is connected to the canister (5). According to the invention --the canister (5) is adapted to receive the counter (15) on a base end (6a), --the counter and/or the canister further having contact parts (18, 20) for their attachment having means for increasing the friction and thereby allowing the counter to fixedly be attached onto the canister in a range of different positions in the lengthwise direction, --the counter further being adapted to during the process to assemble the counter to the canister, be urged onto the canister until the length of the counter and canister together is within a predefined tolerance of a predefined length.
Inventor(s): Hodson; Darren (Leicestershire, GB), Treneman; William (Cambridgeshire, GB)
Assignee: AstraZeneca AB (Sodertaije, SE)
Application Number:11/571,389
Patent Claim Types:
see list of patent claims
Delivery; Device; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
AstrazenecaSYMBICORTbudesonide; formoterol fumarate dihydrateAEROSOL, METERED;INHALATION021929-001Jul 21, 2006RXYesYes► Subscribe► Subscribe► SubscribeY
AstrazenecaSYMBICORTbudesonide; formoterol fumarate dihydrateAEROSOL, METERED;INHALATION021929-002Jul 21, 2006RXYesYes► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 8,616,196

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden0401773Jul 2, 2004
PCT Information
PCT FiledJune 23, 2005PCT Application Number:PCT/SE2005/000994
PCT Publication Date:January 12, 2006PCT Publication Number: WO2006/004496

International Patent Family for Patent: 8,616,196

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada2569923► Subscribe
China1997417► Subscribe
China100563743► Subscribe
Germany602005026526► Subscribe
European Patent Office1768727► Subscribe
Spain2359251► Subscribe
Hong Kong1101895► Subscribe
Japan2008504923► Subscribe
Israel179971► Subscribe
BrazilPI0512848► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Fish and Richardson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: